Experimental oncology
1 – 10 of 59
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma
(
- Contribution to journal › Article
- 2024
-
Mark
Cancer-associated fibroblasts express CD1d and activate invariant natural killer T cells under cellular stress
(
- Contribution to journal › Letter
-
Mark
Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer
(
- Contribution to journal › Article
-
Mark
Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence
(
- Contribution to journal › Article
-
Mark
Cellular plasticity in the breast cancer ecosystem
(
- Contribution to journal › Scientific review
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
-
Mark
Spatial multiomics reveal intratumoral immune heterogeneity with distinct cytokine networks in lung cancer brain metastases
(
- Contribution to journal › Article
-
Mark
Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Retraction note : CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling (Nature Cell Biology, (2021), 23, 7, (758-770), 10.1038/s41556-021-00702-0)
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
177Lu−SN201 nanoparticle shows superior anti−tumor efficacy over conventional cancer drugs in 4T1 orthotopic model
(
- Contribution to journal › Article